Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins

<div>Western blotting analysis of the VP1 protein and the VP1-gp120 and VP1-E2 fusion proteins. (a) Western blotting analysis using the mouse anti-His tag monoclonal antibody as the primary antibody. Lanes 1, 2, and 3 correspond to the VP1 protein and the VP1-gp120 and VP1-E2 fusion proteins, respectively. (b) Western blotting analysis using the anti-type A FMDV VP1 monoclonal antibody as the primary antibody. Lanes 1, 2, and 3 correspond to the VP1 protein and the VP1-gp120 and VP1-E2 fusion proteins, respectively.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins 

Figure 2 | Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins 